Biodesix and Immodulon enter R&D partnership to fight pancreatic cancer

Biodesix and Immodulon enter R&D partnership to fight pancreatic cancer

BOULDER -- Biodesix Inc. and London-based Immodulon Therapeutics Limited, announced they have entered into a biomarker research collaboration. The partnership will focus on the analysis of... Read More

Tuesday July 30, 2019 0 comments Tags: Boulder, Biodesix, Immodulon, David Brunel